- Home
- TRDA vs INNV Comparison
TRDA vs INNV Comparison
Compare TRDA & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRDA
- INNV
- Stock Information
- Founded
- TRDA 2016
- INNV 2007
- Country
- TRDA United States
- INNV United States
- Employees
- TRDA N/A
- INNV N/A
- Industry
- TRDA Biotechnology: Pharmaceutical Preparations
- INNV Medical/Nursing Services
- Sector
- TRDA Health Care
- INNV Health Care
- Exchange
- TRDA Nasdaq
- INNV Nasdaq
- Market Cap
- TRDA 336.6M
- INNV 373.3M
- IPO Year
- TRDA 2021
- INNV 2021
- Fundamental
- Price
- TRDA $8.38
- INNV $3.64
- Analyst Decision
- TRDA Strong Buy
- INNV Sell
- Analyst Count
- TRDA 3
- INNV 2
- Target Price
- TRDA $25.67
- INNV $5.00
- AVG Volume (30 Days)
- TRDA 139.5K
- INNV 36.1K
- Earning Date
- TRDA 05-08-2025
- INNV 05-06-2025
- Dividend Yield
- TRDA N/A
- INNV N/A
- EPS Growth
- TRDA N/A
- INNV N/A
- EPS
- TRDA 0.61
- INNV N/A
- Revenue
- TRDA $172,220,000.00
- INNV $831,683,000.00
- Revenue This Year
- TRDA N/A
- INNV $13.21
- Revenue Next Year
- TRDA N/A
- INNV $10.29
- P/E Ratio
- TRDA $14.69
- INNV N/A
- Revenue Growth
- TRDA 5.74
- INNV 12.19
- 52 Week Low
- TRDA $7.10
- INNV $2.60
- 52 Week High
- TRDA $21.79
- INNV $6.69
- Technical
- Relative Strength Index (RSI)
- TRDA 43.04
- INNV 66.17
- Support Level
- TRDA $7.71
- INNV $2.84
- Resistance Level
- TRDA $9.46
- INNV $3.18
- Average True Range (ATR)
- TRDA 0.60
- INNV 0.26
- MACD
- TRDA 0.05
- INNV 0.08
- Stochastic Oscillator
- TRDA 38.29
- INNV 98.95
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.
About INNV InnovAge Holding Corp.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.